Investigating Maternal Opioid Use, Neonatal Abstinence Syndrome and Response in NW Tribal Communities

调查西北部落社区母亲阿片类药物的使用、新生儿戒断综合症和反应

基本信息

  • 批准号:
    9980845
  • 负责人:
  • 金额:
    $ 19.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-01 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

Abstract (30 lines max) Medical and nonmedical use of prescription opioids has rocketed in the US over the past two decades. The rise in opioid use during pregnancy marked disparities among AI/AN women and newborns. While there are evidence-based treatment strategies recommended for use during pregnancy and in the postnatal use period, use of these strategies is substantially lower in AI/AN across the US. As sovereign nations, tribes are often responsible for policies, practices, and infrastructure improvements to address these problems. The Northwest Tribal Epidemiology Center (The EpiCenter) is tasked with responding to the data needs of the 43 NW Tribes, including Opioid use, Neonatal Abstinence Syndrome (NAS) and access and utilization of treatment related information. We initiate this proposal in response to these requests and needs of the tribes. We plan to perform an epidemiologic assessment to determine the magnitude and impact of maternal substance use during pregnancy and NAS among American Indians in the Northwest. We will leverage ongoing and planned work in the Tribal Epidemiology Center to estimate race- corrected rates and trends of maternal substance use during pregnancy and NAS in hospital discharge data. We will also investigate opioid use and treatment in the NW as reported in Indian Health Service’s national data repository. We will complement these quantitative data with qualitative data to help us understand the environmental, social and organizational structures, processes, and policies, as well as individual behaviors that influence access to, or use of, treatment in Northwest Tribes This proposal will bring together epidemiologic and content experts, as advisory board members to respond to the data and ensure that analyses and reports are useful to decision-makers in various capacities. Upon successful completion of these study aims proposed, we will be poised to implement and evaluate future tribal interventions and policies, which in the long term could reduce the effect of the opioid crisis in Northwest American Indian communities.
摘要(最多 30 行) 过去两年美国处方阿片类药物的医疗和非医疗使用激增 几十年。怀孕期间阿片类药物使用的增加明显表明 AI/AN 妇女和妇女之间存在差异 新生儿。虽然有基于证据的治疗策略建议在 在妊娠期和产后使用期间,这些策略的使用率要低得多 AI/AN 遍布美国。作为主权国家,部落通常对政策、实践、 以及改善基础设施来解决这些问题。西北部落流行病学 中心 (The EpiCenter) 的任务是响应 43 个西北部落的数据需求, 包括阿片类药物的使用、新生儿戒断综合症 (NAS) 以及药物的获取和利用 治疗相关信息。我们发起此提案是为了响应这些请求和需求 部落的。 我们计划进行流行病学评估,以确定疫情的严重程度和影响 西北美洲印第安人在怀孕期间的母体物质使用和 NAS。 我们将利用部落流行病学中心正在进行和计划中的工作来估计种族- 孕期母亲物质使用和住院 NAS 的纠正率和趋势 放电数据。我们还将调查西北地区阿片类药物的使用和治疗,如 印度卫生服务局的国家数据存储库。我们将补充这些定量数据 定性数据帮助我们了解环境、社会和组织 结构、流程和政策,以及影响访问的个人行为,或 西北部落的使用和治疗 该提案将汇集流行病学和内容专家作为顾问委员会成员 对数据做出回应并确保分析和报告对决策者有用 各种能力。成功完成所提出的这些研究目标后,我们将 准备实施和评估未来的部落干预措施和政策,从长远来看 可以减少阿片类药物危机对西北美洲印第安人社区的影响。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Racial Misclassification and Disparities in Neonatal Abstinence Syndrome Among American Indians and Alaska Natives.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JODI A LAPIDUS其他文献

JODI A LAPIDUS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JODI A LAPIDUS', 18)}}的其他基金

Improving Applied Biostatistics Skills for AI/AN Researchers
提高人工智能/AN 研究人员的应用生物统计学技能
  • 批准号:
    10487411
  • 财政年份:
    2021
  • 资助金额:
    $ 19.63万
  • 项目类别:
A NW Tribal EpiCenter Collaboration to Improve the Use of Motor Vehicle Injury Data
西北部落 EpiCenter 合作改善机动车伤害数据的使用
  • 批准号:
    10166615
  • 财政年份:
    2018
  • 资助金额:
    $ 19.63万
  • 项目类别:
A NW Tribal EpiCenter Collaboration to Improve the Use of Motor Vehicle Injury Data
西北部落 EpiCenter 合作改善机动车伤害数据的使用
  • 批准号:
    9924285
  • 财政年份:
    2018
  • 资助金额:
    $ 19.63万
  • 项目类别:
Child Safety Seat Intervention for Pacific Northwest Tribes
太平洋西北部落儿童安全座椅干预
  • 批准号:
    7802905
  • 财政年份:
    2008
  • 资助金额:
    $ 19.63万
  • 项目类别:
Child Safety Seat Intervention for Pacific Northwest Tribes
太平洋西北部落儿童安全座椅干预
  • 批准号:
    8220930
  • 财政年份:
    2008
  • 资助金额:
    $ 19.63万
  • 项目类别:
Child Safety Seat Intervention for Pacific Northwest Tribes
太平洋西北部落儿童安全座椅干预
  • 批准号:
    7493816
  • 财政年份:
    2008
  • 资助金额:
    $ 19.63万
  • 项目类别:
Native Children Always Ride Safe (Native CARS) Study
本土儿童始终安全骑行(本土汽车)研究
  • 批准号:
    8565707
  • 财政年份:
    2008
  • 资助金额:
    $ 19.63万
  • 项目类别:
Native Children Always Ride Safe (Native CARS) Study
本土儿童始终安全骑行(本土汽车)研究
  • 批准号:
    8687738
  • 财政年份:
    2008
  • 资助金额:
    $ 19.63万
  • 项目类别:
Child Safety Seat Intervention for Pacific Northwest Tribes
太平洋西北部落儿童安全座椅干预
  • 批准号:
    8052924
  • 财政年份:
    2008
  • 资助金额:
    $ 19.63万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 19.63万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 19.63万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 19.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 19.63万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 19.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 19.63万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 19.63万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 19.63万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 19.63万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 19.63万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了